{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:50:45Z","timestamp":1758635445895},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.mehy.2007.01.047","type":"journal-article","created":{"date-parts":[[2007,3,28]],"date-time":"2007-03-28T07:17:59Z","timestamp":1175066279000},"page":"925-927","source":"Crossref","is-referenced-by-count":31,"title":["Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia"],"prefix":"10.1016","volume":"69","author":[{"given":"Hamid","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Nejabat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Reza","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mehy.2007.01.047_bib1","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.mehy.2006.06.063","article-title":"A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents","volume":"68","author":"Hosseini","year":"2007","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.mehy.2007.01.047_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2006.09.002","article-title":"Ocular neovascularization: implication of endogenous angiogenic inhibitors and potential therapy","volume":"26","author":"Zhang","year":"2007","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.mehy.2007.01.047_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00003226-200307000-00015","article-title":"Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia","volume":"22","author":"Jin","year":"2003","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.mehy.2007.01.047_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0039-6257(02)00463-0","article-title":"The treatment of pterygium","volume":"48","author":"Hirst","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"10.1016\/j.mehy.2007.01.047_bib5","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ophtha.2006.02.026","article-title":"Efficacy of subconjunctival 5-fluorouracil and triamcinolone injection in impending recurrent pterygium","volume":"113","author":"Prabhasawat","year":"2006","journal-title":"Ophthalmology"},{"issue":"Pt 2","key":"10.1016\/j.mehy.2007.01.047_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/eye.1989.31","article-title":"Pathogenesis of pterygium","volume":"3","author":"Hill","year":"1989","journal-title":"Eye"},{"issue":"9","key":"10.1016\/j.mehy.2007.01.047_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/bjo.67.9.604","article-title":"Histology of pterygium: an electron microscopic study","volume":"67","author":"Cameron","year":"1983","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.mehy.2007.01.047_bib8","first-page":"1963","article-title":"Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis","volume":"42","author":"Di","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.mehy.2007.01.047_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1076\/ceyr.25.1.17.9959","article-title":"Angiogenesis in pterygium: morphometric and immunohistochemical study","volume":"25","author":"Marcovich","year":"2002","journal-title":"Curr Eye Res"},{"issue":"Jun 23","key":"10.1016\/j.mehy.2007.01.047_bib10","article-title":"Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1","author":"Aspiotis","year":"2006","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.mehy.2007.01.047_bib11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00417-002-0589-1","article-title":"Connective tissue growth factor in pterygium: simultaneous presence with vascular endothelial growth factor \u2013 possible contributing factor to conjunctival scarring","volume":"241","author":"van","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.mehy.2007.01.047_bib12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ophtha.2005.01.023","article-title":"Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia","volume":"112","author":"Gebhardt","year":"2005","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.mehy.2007.01.047_bib13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/00003226-200110000-00013","article-title":"Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia","volume":"20","author":"Lee","year":"2001","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.mehy.2007.01.047_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"issue":"Dec 21","key":"10.1016\/j.mehy.2007.01.047_bib15","article-title":"Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration","author":"Aisenbrey","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.mehy.2007.01.047_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.mehy.2007.01.047_bib17","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.iae.0000246884.76018.63","article-title":"Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study)","volume":"26","author":"Jorge","year":"2006","journal-title":"Retina"},{"issue":"Nov 29","key":"10.1016\/j.mehy.2007.01.047_bib18","article-title":"Intravitreal bevacizumab (Avastin) associated with the regression of subretinal neovascularization in idiopathic juxtafoveolar retinal telangiectasis","author":"Jorge","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Dec 19","key":"10.1016\/j.mehy.2007.01.047_bib19","article-title":"Inhibition of experimental corneal neovascularization by Bevacizumab(AVASTIN)","author":"Manzano","year":"2006","journal-title":"Br J Ophthalmol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707001028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707001028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T09:56:29Z","timestamp":1546941389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707001028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0306987707001028"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.01.047","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}